鹭燕医药
(002788)
| 流通市值：33.62亿 | | | 总市值：34.23亿 |
| 流通股本：3.82亿 | | | 总股本：3.89亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 481,541,274.64 | 554,333,721.48 | 458,141,985.69 | 606,302,753.24 |
| 衍生金融资产 | - | - | 0 | - |
| 应收票据及应收账款 | 6,007,231,403.67 | 5,841,096,958.46 | 5,866,750,910.67 | 5,637,073,695.29 |
| 其中：应收票据 | 8,044,317 | - | 0 | - |
| 应收账款 | 5,999,187,086.67 | 5,841,096,958.46 | 5,866,750,910.67 | 5,637,073,695.29 |
| 应收款项融资 | 25,981,594.37 | 20,202,535.55 | 17,807,849.78 | 35,953,467.25 |
| 预付款项 | 340,997,291.85 | 437,788,176.24 | 439,755,842.88 | 314,917,160.74 |
| 其他应收款合计 | 79,987,497.48 | 99,511,870.28 | 115,255,602.82 | 94,591,181.12 |
| 其中:应收利息 | - | - | 0 | - |
| 应收股利 | - | - | 0 | - |
| 存货 | 2,732,696,467.88 | 2,447,014,012.55 | 2,528,472,661.18 | 2,574,076,489.37 |
| 合同资产 | - | - | 0 | - |
| 一年内到期的非流动资产 | - | - | 0 | - |
| 其他流动资产 | 60,139,548.45 | 45,537,904.28 | 55,369,519.3 | 55,658,877.1 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 9,728,575,078.34 | 9,445,485,178.84 | 9,481,554,372.32 | 9,318,573,624.11 |
| 非流动资产: | | | | |
| 债权投资 | - | - | 0 | - |
| 其他债权投资 | - | - | 0 | - |
| 长期应收款 | - | - | 0 | - |
| 长期股权投资 | 48,586,849.79 | 47,101,287.95 | 49,552,514.42 | 43,552,514.42 |
| 其他权益工具投资 | 300,000 | 300,000 | 300,000 | 300,000 |
| 其他非流动金融资产 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 投资性房地产 | 23,066,761.12 | 23,324,552.94 | 23,551,114.53 | 23,777,500.02 |
| 固定资产 | 1,253,707,798.3 | 1,158,250,062.61 | 986,535,209.11 | 917,097,492.64 |
| 在建工程 | 432,320,330.05 | 433,465,510.34 | 588,550,602.78 | 616,586,162.43 |
| 生产性生物资产 | - | - | 0 | - |
| 油气资产 | - | - | 0 | - |
| 使用权资产 | 142,683,682.02 | 139,858,947.54 | 134,786,609.2 | 119,250,798.72 |
| 无形资产 | 363,243,323.12 | 365,875,746.79 | 358,203,453.07 | 355,163,568.35 |
| 开发支出 | - | - | 0 | - |
| 商誉 | 289,281,538.89 | 288,651,455.27 | 288,651,455.27 | 288,651,455.27 |
| 长期待摊费用 | 28,242,943.12 | 28,636,590.63 | 29,272,518.41 | 28,584,076.52 |
| 递延所得税资产 | 78,648,393.09 | 68,280,858.45 | 71,507,202.76 | 66,373,991.23 |
| 其他非流动资产 | 3,460,960.36 | 3,760,960.36 | 3,716,047.61 | 10,683,277.64 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,668,542,579.86 | 2,562,505,972.88 | 2,539,626,727.16 | 2,475,020,837.24 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 12,397,117,658.2 | 12,007,991,151.72 | 12,021,181,099.48 | 11,793,594,461.35 |
| 流动负债: | | | | |
| 短期借款 | 4,214,121,520.75 | 3,923,504,798.9 | 4,156,458,316.83 | 3,990,156,064.21 |
| 交易性金融负债 | - | - | 0 | - |
| 衍生金融负债 | - | - | 0 | - |
| 应付票据及应付账款 | 3,711,758,981.77 | 3,498,457,960.16 | 3,447,518,938.61 | 3,444,468,056.11 |
| 其中：应付票据 | 1,355,665,165.35 | 1,284,027,492.46 | 1,181,736,475.98 | 1,113,806,554.25 |
| 应付账款 | 2,356,093,816.42 | 2,214,430,467.7 | 2,265,782,462.63 | 2,330,661,501.86 |
| 预收款项 | 33,200 | 33,200 | 33,200 | 23,371.24 |
| 合同负债 | 32,295,407.1 | 30,902,005.6 | 24,635,367.8 | 22,356,122.94 |
| 应付职工薪酬 | 43,371,539.12 | 40,182,608.16 | 39,678,707.35 | 65,454,170.74 |
| 应交税费 | 49,367,491.81 | 59,870,311.5 | 72,362,875.33 | 68,989,289.4 |
| 其他应付款合计 | 202,152,567.05 | 230,388,929.53 | 220,330,559.4 | 234,636,779.85 |
| 其中:应付利息 | - | - | 0 | - |
| 应付股利 | - | 189,322.94 | 0 | - |
| 一年内到期的非流动负债 | 169,920,096.96 | 230,200,737.34 | 215,820,695.3 | 197,206,741.78 |
| 其他流动负债 | 4,157,535.61 | 3,926,650.13 | 3,119,385.69 | 2,867,281.25 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 8,427,178,340.17 | 8,017,467,201.32 | 8,179,958,046.31 | 8,026,157,877.52 |
| 非流动负债: | | | | |
| 长期借款 | 629,949,867.81 | 606,378,425.02 | 566,299,561.03 | 578,628,801.23 |
| 应付债券 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 租赁负债 | 108,801,181.82 | 101,023,564.43 | 98,775,298.13 | 74,328,563.18 |
| 长期应付款 | 84,256,476.29 | 85,280,977.73 | 86,723,677.07 | 90,977,952.37 |
| 预计负债 | - | - | 0 | - |
| 递延收益 | 38,957,795.95 | 39,170,029.28 | 39,480,503.65 | 39,755,570.83 |
| 递延所得税负债 | 6,580,679.39 | 6,647,705.46 | 6,714,731.51 | 6,805,044.1 |
| 其他非流动负债 | - | - | 0 | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 868,546,001.26 | 838,500,701.92 | 797,993,771.39 | 790,495,931.71 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 9,295,724,341.43 | 8,855,967,903.24 | 8,977,951,817.7 | 8,816,653,809.23 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 388,516,736 | 388,516,736 | 388,516,736 | 388,516,736 |
| 其他权益工具 | - | - | 0 | - |
| 优先股 | - | - | 0 | - |
| 永续债 | - | - | 0 | - |
| 资本公积 | 616,220,833.39 | 616,220,833.39 | 616,220,833.39 | 631,048,081.18 |
| 减:库存股 | - | - | 0 | - |
| 其他综合收益 | 3,774,649.83 | 4,936,450.93 | 3,847,716.92 | 3,842,541.98 |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 199,283,211.92 | 199,283,211.92 | 199,283,211.92 | 199,283,211.92 |
| 未分配利润 | 1,864,359,597.48 | 1,913,941,343.55 | 1,807,344,238.29 | 1,723,567,806.87 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,072,155,028.62 | 3,122,898,575.79 | 3,015,212,736.52 | 2,946,258,377.95 |
| 少数股东权益 | 29,238,288.15 | 29,124,672.69 | 28,016,545.26 | 30,682,274.17 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 3,101,393,316.77 | 3,152,023,248.48 | 3,043,229,281.78 | 2,976,940,652.12 |
| 负债和股东权益合计 | 12,397,117,658.2 | 12,007,991,151.72 | 12,021,181,099.48 | 11,793,594,461.35 |
| 公告日期 | 2024-10-22 | 2024-08-22 | 2024-04-16 | 2024-04-16 |
| 审计意见(境内) | | | | 标准无保留意见 |